Physician

Aakriti Garg Shukla, M.D.

According to 2025 Medicare claims, Aakriti Shukla, M.D. (NPI: 1578976973) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (NPI: 1508266347; TIN: 135598093) and primary practice location at 10022-4730. Shukla is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Shukla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 606 traditional Medicare patients, billed 3,326 HCPCS/CPT codes, and received $259,428 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,322 prescription claims across 500 beneficiaries totaling $358,699 in drug costs, led by Rhopressa (Netarsudil Mesylate). Open Payments data shows 21 records totaling $11,722. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $39,030 to $259,428. Similarly, Part D prescription costs have risen steadily, from $9,853 to $358,699. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$130K$259K2018 Medicare payment: $39,030 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $89,226 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $93,342 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $116,809 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $136,738 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $188,518 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $259,428 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018260586$39,030
20196081,382$89,226
2020312944$93,342
20214111,236$116,809
20225841,615$136,738
20234392,213$188,518
20246063,326$259,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$203K$406K2015 Drug cost: $9,853 (USD; Tot_Drug_Cst)2016 Drug cost: $17,296 (USD; Tot_Drug_Cst)2017 Drug cost: $74,387 (USD; Tot_Drug_Cst)2018 Drug cost: $165,214 (USD; Tot_Drug_Cst)2019 Drug cost: $380,377 (USD; Tot_Drug_Cst)2020 Drug cost: $257,980 (USD; Tot_Drug_Cst)2021 Drug cost: $325,992 (USD; Tot_Drug_Cst)2022 Drug cost: $405,926 (USD; Tot_Drug_Cst)2023 Drug cost: $290,716 (USD; Tot_Drug_Cst)2024 Drug cost: $358,699 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201541122$9,853
201654253$17,296
20172501,420$74,387
20186412,196$165,214
20199473,275$380,377
20205612,298$257,980
20216002,859$325,992
20227373,353$405,926
20234821,933$290,716
20245002,322$358,699

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system157163$105
92012Established patient problem focused exam of visual system467944$77
92083Exam of visual field with extended testing498842$55
92133Imaging of optic nerve482668$29
92020Exam of the internal drainage system of eye9397$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RhopressaNetarsudil Mesylate1095,439$57,233
LumiganBimatoprost753,865$41,488
Brimonidine TartrateBrimonidine Tartrate1389,444$36,601
CombiganBrimonidine Tartrate/Timolol633,171$25,558
SimbrinzaBrinzolamide/Brimonidine Tart864,242$24,519

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$11,722Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aakriti Garg Shukla, M.D.?

Tedicare shows public-source Medicare data for Aakriti Garg Shukla, M.D. (NPI 1578976973), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aakriti Garg Shukla, M.D. have ACO affiliation data?

Aakriti Garg Shukla, M.D. is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Aakriti Garg Shukla, M.D.?

Aakriti Garg Shukla, M.D. is linked to TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (billing NPI 1508266347) in the available physician profile data.

Does Aakriti Garg Shukla, M.D. have Open Payments data?

Aakriti Garg Shukla, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.